Promising mouse studies and billions of dollars in funding are stoking excitement. But we’ve been here before.

The approach relies on “reprogramming” cells to a younger state. It’s one of many strategies being explored by biotech ...

Cellular reprogramming is the hottest topic in longevity science, with tech titans like Sam Altman investing in it. It's now ...

First human receives reverse-aging gene therapy in groundbreaking trial targeting glaucoma, using cellular reprogramming to ...

The experimental treatment, known as ER-100, is being tested in patients suffering from glaucoma and other forms of ...

Biotech startup NewLimit secures a major funding round after claiming a ‘breakthrough discovery’ of a prototype medicine that ...

The government regards human aging not simply as a natural phenomenon but as a treatable disease, and has officially launched ...

Life Biosciences says it just dosed its first patient in an FDA-approved clinical trial to reverse age-related blindness.

As AI transforms biology, longevity startups are attracting investors, advancing toward clinical milestones, and reshaping ...

Aging is a complex process that has long puzzled scientists. A recent study published in Engineering proposes a new theory called pro-aging metabolic reprogramming (PAMRP), which could change our ...

Weight loss drugs show signs of slowing biological aging, scientists discover - GLP-1 drugs help fight the harmful ...